Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Belgium
  4. Euronext Bruxelles
  5. Biocartis Group NV
  6. News
  7. All News
    BCART   BE0974281132

BIOCARTIS GROUP NV

(BCART)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news
All news about BIOCARTIS GROUP NV
06/22GeneproDX announced that it has received $3.2 million in funding from Biocart..
CI
06/04BIOCARTIS : Results of the Extraordinary Shareholders' Meeting held on 4 June 20..
PU
06/04PRESS RELEASE BIOCARTIS GROUP NV : Results of the Extraordinary Shareholders' Me..
AQ
05/17PRESS RELEASE BIOCARTIS GROUP NV : Invitation to the Extraordinary Shareholders'..
AQ
05/14BIOCARTIS : Results of the Shareholders' Meetings held on 14 May 2021
PU
05/14PRESS RELEASE BIOCARTIS GROUP NV : Results of the Shareholders' Meetings held on..
AQ
05/11BIOCARTIS : Receives EUR 1.4m Grant to Support Development of New Idylla™ ..
PU
05/11PRESS RELEASE BIOCARTIS GROUP NV : Biocartis Receives EUR 1.4m Grant to Support ..
AQ
05/11Biocartis Group NV Receives EUR 1.4 Million Grant to Support Development of N..
CI
05/04ASTRAZENECA : Biocartis Expand Partnership To Make EGFR Testing Available For Lu..
MT
05/04BIOCARTIS : Announces New Collaboration with AstraZeneca to Expand Availability ..
PU
05/04PRESS NEWS BIOCARTIS GROUP NV : Biocartis Announces New Collaboration with Astra..
AQ
05/03Biocartis Announces New Collaboration with Astrazeneca to Expand Availability..
CI
04/22BIOCARTIS : Q1 2021 business update
PU
04/22PRESS RELEASE BIOCARTIS GROUP NV : Biocartis and SkylineDx Sign Collaboration to..
AQ
04/22PRESS RELEASE BIOCARTIS GROUP NV : Biocartis q1 2021 business update
AQ
04/22Biocartis Group NV Reconfirms Production Guidance of 2021
CI
04/22Biocartis and SkylineDx Sign Collaboration to Develop the Merlin Assay, A Tes..
CI
04/20BIOCARTIS : Announces US FDA 510(k) submission of its Idylla™ MSI Test
PU
04/20PRESS RELEASE BIOCARTIS GROUP NV : Biocartis Announces US FDA 510(k) submission ..
AQ
04/20Biocartis Group NV Announces US FDA 510(k) submission of its IdyllaÖ MSI Test
CI
04/13BIOCARTIS : Invitation to the Annual and Extraordinary Shareholders' Meetings
PU
04/13PRESS RELEASE BIOCARTIS GROUP NV : Invitation to the Annual and Extraordinary Sh..
AQ
04/01BIOCARTIS : Announces Publication of 2020 Annual Report
PU
04/01PRESS RELEASE BIOCARTIS GROUP NV : Biocartis Announces Publication of 2020 Annua..
AQ
03/22BIOCARTIS : Launches Kit to Speed Up Gene Fusion Testing
MT
03/22BIOCARTIS : Launches Idylla™ GeneFusion Assay as Rapid Lab Workflow Soluti..
PU
03/22PRESS RELEASE BIOCARTIS GROUP NV : Biocartis Launches Idylla™ GeneFusion A..
AQ
03/22Biocartis Group NV Launches IdyllaÖ GeneFusion Assay as Rapid Lab Workflow So..
CI
02/25Biocartis Group NV Updates on Idylla
CI
02/25PRESS RELEASE BIOCARTIS GROUP NV : Biocartis announces 2020 results and 2021 out..
AQ
02/25Biocartis Group Nv Reports Earnings Results for the Full Year Ended December ..
CI
02/18BIOCARTIS : Announces 2020 Full Year Results on 25 February 2021
PU
02/18PRESS NEWS BIOCARTIS GROUP NV : Biocartis announces 2020 full year results on 25..
AQ
02/02BIOCARTIS' : Idylla EGFR Testing Method Passes Two Clinical Studies
MT
02/02BIOCARTIS : New US Studies Demonstrate Idylla™ Allows Rapid First Assessme..
PU
02/02PRESS NEWS BIOCARTIS GROUP NV : New US Studies Demonstrate Idylla™ Allows ..
AQ
02/02Biocartis Group NV Announces Publication of Two Recent Studies by Memorial Sl..
CI
01/11BIOCARTIS : Meets 2020 key objectives
PU
01/11PRESS NEWS BIOCARTIS GROUP NV : Biocartis meets 2020 key objectives
AQ
2020BIOCARTIS : Disclosure of outstanding voting securities
PU
2020PRESS NEWS BIOCARTIS GROUP NV : Disclosure of outstanding voting securities
AQ
2020PRESS NEWS BIOCARTIS GROUP NV : Biocartis Announces the Conversion of EUR 15 mil..
AQ
2020BIOCARTIS : Disclosure of a transparency notification
PU
2020PRESS NEWS BIOCARTIS GROUP NV - REGU : Disclosure of a transparency notification
AQ
2020BIOCARTIS : Announces Publication of Large Multi-Center Comparison Study with Id..
PU
2020PRESS NEWS BIOCARTIS GROUP NV : Biocartis Announces Publication of Large Multi-C..
AQ
2020Biocartis Group NV Announces Publication of Large Multi-Center Comparison Stu..
CI
2020BIOCARTIS : Announces Ten Idylla™ Studies to be Published at Virtual AMP (..
PU
2020PRESS NEWS BIOCARTIS GROUP NV : Biocartis Announces Ten Idylla™ Studies t..
AQ
2020Biocartis Group NV Announces Ten IdyllaÖ Studies to be Published at Virtual A..
CI
2020BIOCARTIS : Q3 2020 business update
PU
2020PRESS NEWS BIOCARTIS GROUP NV : Biocartis q3 2020 business update
AQ
2020PRESS NEWS BIOCARTIS GROUP NV : Biocartis Announces CE-marking of its Fully Auto..
AQ
2020BIOCARTIS : Announces Partnership with Endpoint Health to Develop Novel Companio..
PU
2020BIOCARTIS : and GeneproDx To Collaborate on Fully Automated ThyroidPrint« test o..
PU
2020PRESS NEWS BIOCARTIS GROUP NV : Biocartis and GeneproDx To Collaborate on Fully..
AQ
2020PRESS NEWS BIOCARTIS GROUP NV : Biocartis Announces Partnership with Endpoint He..
AQ
2020Biocartis Group NV Announces Partnership with Endpoint Health to Develop Nove..
CI
2020Biocartis and Geneprodx to Collaborate on Fully Automated Thyroidprint Test o..
CI
2020PRESS NEWS BIOCARTIS GROUP NV : Biocartis and Exact Sciences Agree to End Collab..
AQ
2020PRESS NEWS BIOCARTIS GROUP NV : Update on the partnership with Exact Sciences
AQ
2020PRESS NEWS BIOCARTIS GROUP NV : Biocartis Announces Market Release of SeptiCyte..
AQ
2020Biocartis Group Nv Announces Market Release of Septicyte« Rapid Test on Idyll..
CI
2020CORPORATE STATEMENT : Biocartis Joins COVID-19 Testing Industry Consortium of Ni..
PU
2020PRESS NEWS BIOCARTIS GROUP NV : Biocartis Receives EUR 1.2 million Grant for Dev..
AQ
2020BIOCARTIS : Results of the Extraordinary Shareholders' Meeting held on 25 Septem..
PU
2020PRESS NEWS BIOCARTIS GROUP NV : Results of the Extraordinary Shareholders' Meeti..
AQ
2020BIOCARTIS : Large Prospective Lung Cancer Study To Be Presented at ESMO Congress..
PU
2020BIOCARTIS : Large Prospective Lung Cancer Study To Be Presented at ESMO Congress..
AQ
2020PRESS NEWS BIOCARTIS GROUP NV : Invitation to the Extraordinary Shareholders' Me..
AQ
2020PRESS NEWS BIOCARTIS GROUP NV : Biocartis announces h1 2020 results
AQ
2020Biocartis Group NV Reinstates Earnings Guidance for the Full Year of 2020
CI
2020PRESS NEWS BIOCARTIS GROUP NV : Results of the Extraordinary Shareholders' Meeti..
AQ
2020PRESS NEWS BIOCARTIS GROUP NV : Biocartis Expands Collaboration with LifeArc
AQ
1  2  3  4  5  6Next
Upcoming event on BIOCARTIS GROUP NV
09/02/21